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This study was designed to determine the level of glycaemic control among diabetic patients and to assess the 
relative associations with some diabetic complications. Subjects for this study were diabetic volunteers (diagnosed 
using the 1999 who criteria), who willingly granted their informed consent. They reported at the diabet c clinic of 
the Federal Medical Centre (FMC) Umuahia where their w ights (in kg), heights (in metres), age of subject, sex, 
type and duration of diabetes mellitus and body mass index (BMI) were measured/calculated and recorded. The data 
obtained were analysed using the statistical package for social sciences (SPSS). The student t-test wa used and P <
0.05 was considered as statistically significant. The results show that only 38% of the subjects had good diabetic 
control while poor glycaemic control was seen in 62% of the subjects. Poor control was more prevalent among 
females than males and also associated with more diabetic complications than in subjects with good control. Thus, 
regular and prompt diabetic care is strongly encouraged to reduce the increasing prevalence of poor glycaemic 
control and the associated cardiovascular health burden. 
 




Diabetes mellitus (DM) is a metabolic disorder primarily characterized by elevated blood sugar levels, 
macrovascular and microvascular complications that substantially increase the morbidity and mortality associated 
with the disease and reduce the quality of life of the affected individual (Klein, 1995). It is associated with absolute 
or relative deficiencies in insulin action and/or insulin secretion (WHO, 1985). 
 
The World Health Organization (WHO) classification defines the underlying etiology of type 2 diabetes as defects 
in insulin secretion, with a major contribution from insulin resistance (Scheen, 2006). It is the commnest endocrine 
disease whose prevalence is said to be on the increase globally (Amos et al., 1997). Whilst type 1 DM appears to be 
uncommon in the developing countries, type 2 DM on the other hand, is at its highest prevalence in non-Caucasoid 
communities (King and Zinnet, 1988). However, regardless of the contributions of defects in insulin sensitivity 
versus insulin secretion, defective function of thepancreatic B-cells is now accepted as the hallmark of type 2 
diabetes (Scheen, 2006; Kahn, 2003). 
 
It is now well accepted that the best biochemical indicator of long-term glycaemic control in DM is the estimation of 
glycated haemoglobin (HBA) (Malik et al., 1996 ; Bachusr, 1996 ; Uchefuna and Mba, 2003). Glycated 
haemoglobin is derived from haemoglobin a, which is the major component of adult haemoglobin. Formation of 
HBA begins during erythropoiesis and continues through the 120-day life span of the red blood cells. Formation of 
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HBA is irreversible and the level in the red blood cells depends on the concentration of blood glucose, so that a 
single HBA value reflects the average blood glucose concentration for the preceding 8-12 weeks (Compagnucci et 
al., 1981). 
 
The oxidative stress – over production of superoxide, nduced by hyperglycaemia is the pivotal pathogenic factor 
mediating the emergence of diabetic complications in type 2 diabetes, while also producing increased car iovascular 
risk by enhancing macrovascular complications (Ceriello, 2006). The over production of superoxide at the 
mitochondrial level may also be involved in damaging B-cells, leading to their failure and overt diabetes. 
 
It is known that loss of glycaemic control is predominantly due to progressive B-cell dysfunction, with the 
contribution of different factors mainly glucose toxicity and oxidative stress. The oxidative stress can lead to an 
increase in apoptosis in B cells and therefore contributes to the progressive deterioration of B-cell function in type 2 
diabetes (Kaneto et al., 1996; De guema et al., 2005). The pathophysiology of type 2 diabetes, as well as the 
therapeutic goal of achieving strict glycaemic contr l as soon as possible, and to maintain this in the long-term, 
provides the rationale for the use of appropriate drugs early in the disease (Schemethaner, 2004). 
 
Poor glycaemic control causes the accumulation of sorbitol and advanced glycaemic end products which are 
responsible for causing the chronic complications of DM (Brownlec, 1994). Diabetes mellitus is a lifelong disease 
and so there is a tendency that the morbidity associated with it will also increase with time (Ihekwaba and Ojule, 
2001). Studies have shown that DM and its related complications were responsible for nearly 10% of medical deaths 
(Chukwak et al., 1999). 
 
Studies done in types 1 and 2 DM subjects have shown unequivocally that strict control of the blood glucose 
prevents or delays the progression of diabetic complications (DCCTRG, 1993; UKPDSG, 1998). Strict glycaemic 
control is now the corner stone of management of person with DM (Unadike et al., 2010). 
 
This study therefore, investigates the degree of glycaemic control amongst persons attending the diabetes clinic of 
the Federal Medical Centre (FMC) Umuahia, in South Eastern Nigeria. 
 
MATERIALS AND METHODS 
 
Study duration and protocol: The study lasted between June and December 2010 and the national protocols for 
utilizing human subjects were closely adhered to. Hwever, the study was conducted in compliance with the 
declaration on the right of the patient (WMA, 2000). 
 
Participants: One hundred and twenty (120) confirmed diabetic mellitus subjects 55 males (46 %) and 65 females 
(54%) were involved in this study. They were made up of diabetic volunteers, diagnosed using the 1999 who criteria 
(WHO, 1999), who willingly granted their informed consent and who also attended the diabetic clinic of the 
hospital. 
 
Study procedure, sample collection and analysis: All the subjects who gave consent were weighed on light
clothing using the DAN5 weighing scale (Seca, Uk) which was regularly standardized with a 10kg steel wight. 
Height was measured using a standard meter rule mounted on a stand. From both measurements, the body mass 
indices (BMI) was calculated using the formula BMI = weight (in kg)/ height (in meters)2 (Garrow and Webster, 
1999). Glycaemic control was assessed using glycated haemoglobin (HBAic) which was assayed using the 
chromatography method (Jayness et al., 1985). Poor glycaemic control was defined as a HBAic level of >7% and 
good glycaemic control defined as a HBAic <7%. 
 
Statistical analysis: data analysis was done using the SPSS version 10. Comparsion of means was done using the 




The demographic profile of the study population is shown in table 1.there were fifty-five males and sixty-five 
females, aged between ten seventy-nine years. The clinical characteristics of the study subjects are shown in tables 
2-4. The mean age of the study subjects was 54.7+8.7years, while the mean body mass index was 28.6+3.4kg/m2 
with mean glycated heamoglobin of 8.4+1.7%. 
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Forty-six (38%) of the subjects had good glycaemic control, while seventy four (62%) had poor control. Twenty six 
males (22%) had good glycaemic control while twenty ine (24%) had poor glycaemic control. Twenty females 
(17%) had good glycaemic control while forty-five fmales (38%) had poor glycaemic control. One hundred and 
fourteen subjects had type 2DM while six were type 1 DM persons. Forty-two of the one hundred and fourteen DM 
subjects (37%) who had type 2DM had good glycaemic control, while four (67%) type 1DM had good glycaemic 
control and this was not statistically significant (p>0.05). 
 
Table 1: Demographic profile of the study population 
Age range Males number Females number Total number 
10 – 19 4 2 6 
20 – 29 3 2 5 
30 – 39 5 7 12 
40 – 49 10 14 24 
50 – 59 18 20 38 
60 – 69 11 14 25 
70 – 79 4 6 10 
Total 55 65 120 
 





Age 54.7 + 8.7 years 
BMI 28.6 + 3.4 kg/m2 
Duration of DM 6.3+ 4.7 years 
HB Aic 8.4 + 1.7% 
Key: BMI = Body Mass Index, DM = Diabetes Mellitus. HBAIC = Glycated Haemoglobin. 
 






Males     26 29 55 
Females  20 45 65 
Total      46 74 120 
 






Type 1 DM         4 2 6 
Type 2 DM        42 72 114 




The importance of tight blood glucose control in preventing and/or delaying the progression of complications in 
diabetic patients has been identified by many studies (DCCTRG, 1993; UKPDSG, 1998a). In the widely 
acknowledged Diabetes Control and Complications Trial (DCCT) and the Stockholm Diabetes Intervention study 
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done in type 1 diabetic patients, it was shown uneqivocally, that lowering blood glucose delayed the onset and 
slowed the progression of complications (DCCTRG, 1993). In the DCCT study, it was shown that the incidence or 
progression of retinopathy reduced by 54% - 76% and the need for photocoagulation was therefore reduced by 56%. 
Also the incidence of clinical albuminuria was reduced by 54% and clinical neuropathy by 69%. There was also a 
general reduction in diabetic complications as glycaemic levels approached the normal range. 
 
In the United Kingdom Prospective Diabetes Study (UKPDS) done in type 2 diabetic patients, it was clearly shown 
that retinopathy, nephropathy and neuropathy were rduced by the lowering of the blood glucose levels with 
intensive therapy in which a mean HBA1c of 7.0% was achieved (UKPDSG, 1998a). It was also shown that for every 
percentage point decrease in HBAic, there was a 25% reduction in diabetes related deaths;  7% reduction in all 
cause of mortality and an 18% reduction in combined fatal and non fatal myocardial infarction (UKPDSG, 
1998a,b,c; KCSG, 1998). The guidelines for management of DM recommend intensive control of blood glucose 
reaching glycated haemoglobin level of less than 7%, since this was associated with reduced morbidity and mortality 
(ADA, 2004). However, despite all the wealth of evidence available as to the benefit of good glycaemic control in 
preventing diabetic complications, studies have shown that good glycaemic control is not achieved in many diabetic 
patients (Qari, 2005; Azab, 2001; Khattah et al, 2000; Akbar, 2001). This may be associated with a lowlevel of 
health education about drug compliance and treatment in majority of the diabetic patients. 
 
In this study, good glycaemic control was seen in only 38% of the subjects while poor glycaemic control was seen in 
as many as 62% of the subjects. The possible reasons for this poor control include low level of literacy/health 
education amongst our people, poverty, poor health seeking behaviour of our people, poor compliance and
adherence with follow up visits and medication, over-d pendence on quack medical practitioners and prayer houses. 
Many diabetic patients in our society also make use of alternative medicines including leaves, roots and herbs in 
treating their ailments. All these constitute a great delay before the patients present at the appropriate health facility. 
 
A study by Qari (2005), done among Saudi persons with diabetes mellitus, poor glycaemic control was seen in 42% 
of the subjects. In other studies done in other countries, poor glycaemic control was also seen in most of the subjects 
(Azab, 2001; Khattah et al., 2000; Akbar, 2001). The study by Otieno et al. (2003) in Nairobi, Kenya, showed that 
the majority of the persons with diabetes mellitus had poor glycaemic control and this was presumed to be due to 
suboptimal medication (fake drugs) and deteriorating diabetes (late presentation at diabetic clinics). 
 
In a similar study in Calabar, Nigeria, 63% of the subjects had poor glycaemic control (John et al., 2005). Factors 
identified for the poor glycaemic control in that study included poverty, illiteracy and poor compliance and 
adherence with medications. The study by Coker and Fasanmade (2006), in Lagos, Nigeria, documented poor
glycaemic control as well. In their study, the mean glycated haemoglobin (HBAic) level was 10.5%. They concluded 
also that both physicians and patients’ dependent factors were responsible for the poor outcome. The study by 
Adebisi et al (2007), in Ilorin, Nigeria, also documented this poor glycaemic control in 500 persons with diabetes 
mellitus and the mean HBAic level was 8.0%. It is therefore evident from these studies that poor glycaemic control is 
common in Nigerian persons with diabetes mellitus. The problem may even be getting worse from the results of this 
present study on account of the rising inflation. 
 
The low rates of good glycaemic control in this study calls for more urgent attention. With the overwhelming 
evidence that good glycaemic control prevents or delays diabetic complications, efforts must be intensified by 
medical personnel looking after persons with DM to educate them on the benefits of adhering strictly to medical 
nutrition therapy, and medications to prevent these complications. A recent study has shown that the occurrence of 
severe hypoglycaemia is associated with increased mortality amongst patients with type 2 diabetes and other 
cardiovascular risk factors (Bonds et al., 2010). Consequently, good glycaemic control must be achieved without 
causing hypoglycaemia. 
 
About 20% of patients with type 2 DM have hypertriglyceridaemia or low high density lipo-proteins (HDL) 
cholesterol levels (Laakso, 1997). These abnormalities are powerful risk factors for coronary artery disease in these 
patients and are common in those with poor glycaemic control. Diabetic patients with dyslipidaemia frequ ntly 
develop atherosclerosis and consequently hypertension. Superoxide, which is present in diabetic patients with 
dyslipidaemia is suspected to play an important role in the initiation of this atherosderosis (Hiramatsu and Arimori, 
1998). Also poor glycaemic control may contribute to diabetic dyslipidaemic and erectile dysfunction (ED) 
(Unadike et al., 2008). Diabetes mellitus is an important organic cause of erectile dysfunction with a prevalence rate 
of 75% after 30 years of duration of the disease, and the incidence of ED is three times higher in diabetes than in 
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non-diabetes (Romeo et al., 2000). It is therefore extremely important to aggressively manage all the major 
cardiovascular risk factors especially hypertension and dyslipidaemia. 
 
Hyperglycaemia increases the risk of ED. High glucose levels affect the vasculature and result in the accumulation 
of advanced glycation end products which promote vascular disease and neuropathy, thus contributing to ED 
(Thomas and Chook, 2004). Penile erections rely on neural stimulation of the penile vasculature endothelium and 
corpus cavernosum lacunae to trigger lacunae and smooth muscle relaxation and vasodilation which spurs filling and 
erection (De vriese et al., 2000). Poor glycaemic control induces cardiovascular risk factors like hyperlipidaemia 
which cause vascular damage and thus diminish the response at a number of steps, thereby promoting ED (Lu, 
2000). 
 
Evidence shows that strict glycaemic control substantially reduces the risk of developing complications such as 
blindness, kidney failure and heart disease and slows their progression, thus improving quality of life (Diabetes facts 
and figures, 2006). It must be pointed out here that the average cost of a test for glycated haemoglobin in our society 
is high at about N3000 ($ 22). Consequently, most patients continue to use blood glucose for glycaemic control 
since they cannot afford the much better but costlier glycated haemoglobin test, hence the low number of patients 
used in this study. With the increasing prevalence of diabetes in our society (Ngwogu et al., 2012), we recommend 
that diabetes care and cost of glycated haemoglobin tests be subsidized by the government to help ensur  a wider 
usage of this method, as well as good glycaemic control. Also health education on diabetic care should be made 
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